A new biomarker that predicts colonic neoplasia outcome in patients with hyperplastic colonic polyps

Cancer Prevention Research

Volumn 5, Issue 4, 2012, Pages 675-684

  Do, Catherine ^a   Bertrand, Claudine ^a   Palasse, Julien ^a   Delisle, Marie Bernadette ^b   Shulkes, Arthur ^c   Cohen Jonathan Moyal, Elizabeth ^a   Ferrand, Audrey ^a   Seva, Catherine ^a  

^a CANCER RESEARCH CENTER OF TOULOUSE   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROGASTRIN; GASTRIN; PROTEIN PRECURSOR; TUMOR MARKER;

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; COLON CARCINOGENESIS; COLON POLYP; COLON TUMOR; COLORECTAL CARCINOMA; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TUMOR RECURRENCE; BIOSYNTHESIS; COHORT ANALYSIS; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COLONIC NEOPLASMS; COLONIC POLYPS; DISEASE-FREE SURVIVAL; FEMALE; GASTRINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROTEIN PRECURSORS; REPRODUCIBILITY OF RESULTS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84864837585     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0408     Document Type: Article

References (38)

1. Huang CS, O'Brien MJ, Yang S, Farraye FA. Hyperplastic polyps, serrated adenomas, and the serrated polyp neoplasia pathway. Am J Gastroenterol 2004;99:2242-55. (Pubitemid 39524717)
2. Jeevaratnam P, Cottier DS, Browett PJ, Van De Water NS, Pokos V, Jass JR. Familial giant hyperplastic polyposis predisposing to colorectal cancer: a new hereditary bowel cancer syndrome. J Pathol 1996;179:20-5. (Pubitemid 26180082)
3. Renaut AJ, Douglas PR, Newstead GL. Hyperplastic polyposis of the colon and rectum. Colorectal Dis 2002;4:213-5. (Pubitemid 34567883)
4. Torlakovic E, Snover DC. Serrated adenomatous polyposis in humans. Gastroenterology 1996;110:748-55. (Pubitemid 26071842)
5. Warner AS, Glick ME, Fogt F. Multiple large hyperplastic polyps of the colon coincident with adenocarcinoma. Am J Gastroenterol 1994; 89:123-5. (Pubitemid 24020067)
6. Huang EH, Whelan RL, Gleason NR, Maeda JS, Terry MB, Lee SW, et al. Increased incidence of colorectal adenomas in follow-up evaluation of patients with newly diagnosed hyperplastic polyps. Surg Endosc 2001;15:646-8. (Pubitemid 32622606)
7. Goldstein NS, Bhanot P, Odish E, Hunter S. Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol 2003;119:778-96. (Pubitemid 37047838)
8. Jass JR. Hyperplastic polyps and colorectal cancer: is there a link? Clin Gastroenterol Hepatol 2004;2:1-8. (Pubitemid 38165392)
9. Jass JR, Young J, Leggett BA. Hyperplastic polyps and DNA microsatellite unstable cancers of the colorectum. Histopathology 2000;37: 295-301.
10. Torlakovic E, Skovlund E, Snover DC, Torlakovic G, Nesland JM. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 2003;27:65-81. (Pubitemid 36014900)
11. Bond JH. Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 2000; 95:3053-63.
12. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM. American College of Gastroenterology guidelines for colorectal cancer screening 2009 (corrected). Am J Gastroenterol 2009; 104:739-50.
13. Singh P, Velasco M, Given R, Varro A, Wang TC. Progastrin expression predisposes mice to colon carcinomas and adenomas in response to a chemical carcinogen. Gastroenterology 2000;119:162-71. (Pubitemid 30452589)
14. Wang TC, Koh TJ, Varro A, Cahill RJ, Dangler CA, Fox JG, et al. Processing and proliferative effects of human progastrin in transgenic mice. J Clin Invest 1996;98:1918-29. (Pubitemid 26359210)
15. Baldwin GS, Hollande F, Yang Z, Karelina Y, Paterson A, Strang R, et al. Biologically active recombinant human progastrin(6-80) contains a tightly bound calcium ion. J Biol Chem 2001;276:7791-6.
16. Brown D, Yallampalli U, Owlia A, Singh P. pp60c-Src Kinase mediates growth effects of the full-length precursor progastrin1-80 peptide on rat intestinal epithelial cells, in vitro. Endocrinology 2003;144:201-11. (Pubitemid 36076109)
17. Hollande F, Lee DJ, Choquet A, Roche S, Baldwin GS. Adherens junctions and tight junctions are regulated via different pathways by progastrin in epithelial cells. J Cell Sci 2003;116:1187-97. (Pubitemid 36410658)
18. Singh P, Lu X, Cobb S, Miller BT, Tarasova N, Varro A, et al. Progas-trin1- 80 stimulates growth of intestinal epithelial cells in vitro via high-affinity binding sites.AmJ Physiol Gastrointest Liver Physiol 2003;284:G328-39. (Pubitemid 36120139)
19. Umar S, Sarkar S, Cowey S, Singh P. Activation of NF-kappaB is required for mediating proliferative and antiapoptotic effects of progastrin on proximal colonic crypts of mice, in vivo. Oncogene 2008;27:5599-611.
20. Wu H, Owlia A, Singh P. Precursor peptide progastrin(1-80) reduces apoptosis of intestinal epithelial cells and upregulates cytochrome c oxidase Vb levels and synthesis of ATP. Am J Physiol Gastrointest Liver Physiol 2003;285:G1097-110. (Pubitemid 37448996)
21. Ferrand A, Bertrand C, Portolan G, Cui G, Carlson J, Pradayrol L, et al. Signaling pathways associated with colonic mucosa hyperproliferation in mice overexpressing gastrin precursors. Cancer Res 2005; 65:2770-7. (Pubitemid 40490079)
22. Ferrand A, Wang TC. Gastrin and cancer: a review. Cancer Lett 2006;238:15-29. (Pubitemid 44183758)
23. Bertrand C, Kowalski-Chauvel A, Do C, Résa C, Najib S, Daulhac L, et al. A gastrin precursor, gastrin-gly, upregulates VEGF expression in colonic epithelial cells through an HIF-1-independent mechanism. Int J Cancer 2010;126:2847-57.
24. Grabowska AM, Hughes J, Watson SA. Use of interfering RNA to investigate the role of endogenous gastrin in the survival of gastrointestinal cancer cells. Br J Cancer 2007;96:464-73. (Pubitemid 46215218)
25. Nemeth J, Taylor B, Pauwels S, Varro A, Dockray GJ. Identification of progastrin derived peptides in colorectal carcinoma extracts. Gut 1993;34:90-5. (Pubitemid 23015957)
26. Siddheshwar RK, Gray JC, Kelly SB. Plasma levels of progastrin but not amidated gastrin or glycine extended gastrin are elevated in patients with colorectal carcinoma. Gut 2001;48:47-52. (Pubitemid 32042641)
27. Van Solinge WW, Nielsen FC, Friis-Hansen L, Falkmer UG, Rehfeld JF. Expression but incomplete maturation of progastrin in colorectal carcinomas. Gastroenterology 1993;104:1099-107. (Pubitemid 23090763)
28. Smith AM, Watson SA. Gastrin and gastrin receptor activation: an early event in the adenoma-carcinoma sequence. Gut 2000;47:820-4.
29. Ciccotosto GD, McLeish A, Hardy KJ, Shulkes A. Expression, processing, and secretion of gastrin in patients with colorectal carcinoma. Gastroenterology 1995;109:1142-53.
30. Breiman L. Arcing classifiers. Ann Stat 1998;26:801-24.
31. Efron B. Bootstrap methods: another look at the jackkinfe. Ann Stat 1979;7:1-26.
32. Binquet C, Verret C, Chêne G, Salmi LR, Letenneur L, Palmer G, et al. [Major statistical software usable in epidemiology]. [Article in French]. Rev Epidemiol Sante Publique 1998;46:329-36.
33. Noffsinger AE. Serrated polyps and colorectal cancer: new pathway to malignancy. Annu Rev Pathol 2009;4:343-64.
34. Chakladar A, Dubeykovskiy A, Wojtukiewicz LJ, Pratap J, Lei S, Wang TC. Synergistic activation of the murine gastrin promoter by oncogenic Ras and beta-catenin involves SMAD recruitment. Biochem Biophys Res Commun 2005;336:190-6. (Pubitemid 41253420)
35. Koh TJ, Bulitta CJ, Fleming JV, Dockray GJ, Varro A, Wang TC. Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis. J Clin Invest 2000;106:533-9. (Pubitemid 30666386)
36. Chan TL, Zhao W, Leung SY, Yuen ST. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res 2003;63:4878-81. (Pubitemid 37022620)
37. O'Brien MJ, Yang S, Mack C, Xu H, Huang CS, Mulcahy E, et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 2006;30: 1491-501. (Pubitemid 44808785)
38. Nakata H, Wang SL, Chung DC, Westwick JK, Tillotson LG. Oncogenic ras induces gastrin gene expression in colon cancer. Gastroenterology 1998;115:1144-53. (Pubitemid 28485605)